PCSK9(D374T) [Biotinylated]-LDLR Binding Assay Kit

Only %1 left
Catalog #
78326
As low as $750 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PCSK9(D374T) [Biotinylated]-LDLR Binding Assay Kit is designed for screening and profiling purposes. This assay takes advantage of the high sensitivity of detection of biotin-labeled PCSK9(D374T) by streptavidin-HRP. Only a few steps are required for the assay. First, LDLR ectodomain is coated on a 384-well plate. Next, PCSK9(D374T) is incubated with LDLR on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader.

Need us to run inhibitor screens or profile your compounds against PCSK9(D374T)-LDLR? Check out our PCSK9 Screening Services.

Synonyms
Biotinylated PCSK9, FH3, HCHOLA3, PC9, NARC1, Neural Apoptosis Regulated Convertase 1, FH, FHC, LDLR, LDLCQ2, low density lipoprotein receptor
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Mutation
D374T
Supplied As
The kit comes in a convenient 96 or 384-well format, with biotin-labeled mutant protein PCSK9(D374T), purified LDLR ectodomain, streptavidin-labeled HRP, and assay buffer for 100 or 384 reactions.
Materials Required But Not Supplied
  • PBS buffer (Phosphate Buffer Saline)
  • Luminometer or microplate reader capable of reading chemiluminescence
  • Rotating or rocker platform
Format

96 reactions

Catalog # Name Amount Storage
71211 PCSK9(D374T), Biotin-Labeled* 10 µg -80°C
71205 LDLR* 10 µg -20°C
79742 Streptavidin-HRP 10 µl -20°C
33298 3x PL-01 Assay Buffer 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
79670 ELISA ECL Substrates A and B (2 components) 6 ml each Room Temp.
79699 96-well plate, white 1 +4°C

* The concentration of protein is lot-specific and will be indicated on the tube containing the protein

384 reactions

Catalog # Name Amount Storage
71211 PCSK9(D374T), Biotin-Labeled* 2 x 10 µg -80°C Avoid multiple freeze/ thaw cycles
71205 LDLR, FLAG-Tag* 2 x 10 µg -80°C
79742 Streptavidin-HRP 2 x 10 µl 4°C
33298 3x PL-01 Assay Buffer 2 x 50 ml -20°C
79728 Blocking Buffer 2 2 x 50 ml 4°C
79670 ELISA ECL Substrate A (translucent bottle) 2 x 6 ml Room Temp
ELISA ECL Substrate B (brown bottle) 2 x 6 ml Room Temp
78188 384-well plate 1 Room Temp  

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
PCSK9: Q8NBP7; LDLR: P01130
Background

PCSK9 (Proprotein convertase subtilisin/kexin type 9) functions as a negative regulator of hepatic low-density lipoprotein receptors (LDLRs) by binding to the LDLR ectodomain. The D374T mutation is associated with hypercholesterolemia; this form of PCSK9 is more potent at decreasing LDL uptake than wild-type PCSK9, most likely by increasing the binding affinity of PCSK9 for the LDLR.

References

1. Chan, J.C. et al. (2009). Natl Acad. Sci. USA, 106, 9820-9825.
2. Liang, H., et al. (2012) Pharmacol. Exp. Ther. 340, 2289-236.